Response from Pr21 Oct 2020 18:11
Dear Jamie,
GDR are still waiting on approval from the Indian regulatory authorities and this news will be released to the market via RNS when we can.
The Company has received over £1.0m of indicative orders for the Genedrive® 96 SARS-CoV-2 test, but regulatory approvals are required to fulfil these orders and ship the product. Additionally, it may not always be possible to disclose specific countries, nor customers, for commercial reasons.
Kind regards,
Anna